Laura Badger, MS CCC-SLP - Speech-Language Pathologist in Arlington, MA

Laura Badger, MS CCC-SLP is a Speech-language Pathologist based in Arlington, Massachusetts. Laura Badger is licensed to practice in Massachusetts (license number 8380) and her current practice location is 11 Menotomy Rd, Arlington, Massachusetts. She can be reached at her office (for appointments etc.) via phone at (845) 518-5365.

NPI number for Laura Badger is 1427489632 and her current mailing address is 11 Menotomy Rd, Arlington, Massachusetts. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1427489632.

Contact Information

Laura Badger, MS CCC-SLP
11 Menotomy Rd,
Arlington, MA 02476-6109
(845) 518-5365
Not Available



Healthcare Provider's Profile

Full NameLaura Badger
GenderFemale
SpecialitySpeech-language Pathologist
Location11 Menotomy Rd, Arlington, Massachusetts
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1427489632
  • Provider Enumeration Date: 12/13/2013
  • Last Update Date: 01/20/2014

Medical Identifiers

Medical identifiers for Laura Badger such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1427489632NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist 8380 (Massachusetts)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Laura Badger is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Laura Badger, MS CCC-SLP
11 Menotomy Rd,
Arlington, MA 02476-6109

Ph: (845) 518-5365
Laura Badger, MS CCC-SLP
11 Menotomy Rd,
Arlington, MA 02476-6109

Ph: (845) 518-5365

News Archive

Researchers identify second type of complete sporadic disease

A new sporadic prion protein disease has been discovered. Variably protease-sensitive prionopathy, as it has been named, is the second type of complete sporadic disease to be identified since Creutzfeldt-Jakob disease was reported in the 1920s. The landmark finding from the National Prion Disease Pathology Surveillance Center at Case Western Reserve University is published in the August issue of Annals of Neurology.

Verastem closes $16 million Series A financing

Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat cancer by targeting cancer stem cells, today announced the closing of a $16 million Series A financing. Founding investor, Longwood Founders Fund, was joined by Bessemer Venture Partners, Cardinal Partners, and MPM Capital.

NsXeR protein: A new optogenetic tool to control muscle and neuronal cells

Scientists have examined a protein that will find application in optogenetics and could be used to control muscle and neuronal cells. The paper on the light-sensitive NsXeR protein of the xenorhodopsin class was published in Science Advances by the international team of researchers from MIPT, Research center Jülich, and Institut de Biologie Structurale.

Roche announces acquisition of Signature Diagnostics

Roche announced today the acquisition of Signature Diagnostics AG, a privately held company based in Potsdam, Germany. Signature is a translational oncology and genomics company that develops large blood plasma and tissue biobanks in multiple cancers, including colorectal and lung, which are constructed from multicenter prospective clinical studies.

Read more News

› Verified 9 days ago


Speech-Language Pathologist in Arlington, MA

Ms. Sarah Driscoll Brundige, MS, CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 15 Herbert Rd, Arlington, MA 02474
Phone: 617-921-2313    
Ms. Ellen Miller, CCC/SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 51 Hawthorne Ave, Arlington, MA 02476
Phone: 781-454-7561    
Ms. Sara E Saba, M.S. CCC SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 180 Massachusetts Ave, Suite 301, Arlington, MA 02474
Phone: 781-483-3171    Fax: 781-483-3162
Tai Diamond, MA, CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 83 Appleton St, Arlington, MA 02476
Phone: 781-696-8161    
Ruth Smolash, MC, CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 534 Summer St, Arlington, MA 02474
Phone: 781-307-7462    
Valerie Johnson, M.ED., CCC/SP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 37 Broadway, Suite 2, Arlington, MA 02474
Phone: 781-643-6090    Fax: 781-643-7395

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.